Fig. 1From: Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence ScoresConsolidated Standards of Reporting Trials (CONSORT) diagram showing inclusion and exclusion criteria for this study. ER estrogen receptor, Her2 human epidermal growth factor receptor 2, NCDB National Cancer Database, PR progesterone receptor, RS Recurrence ScoreBack to article page